Literature DB >> 22030098

Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.

Annie M Behrend1, Cary O Harding, James D Shoemaker, Dietrich Matern, David J Sahn, Diane L Elliot, Melanie B Gillingham.   

Abstract

BACKGROUND: The use of long-chain fatty acids (LCFAs) for energy is inhibited in inherited disorders of long-chain fatty acid oxidation (FAO). Increased energy demands during exercise can lead to cardiomyopathy and rhabdomyolysis. Medium-chain triglycerides (MCTs) bypass the block in long-chain FAO and may provide an alternative energy substrate to exercising muscle.
OBJECTIVES: To determine the influence of isocaloric MCT versus carbohydrate (CHO) supplementation prior to exercise on substrate oxidation and cardiac workload in participants with carnitine palmitoyltransferase 2 (CPT2), very long-chain acyl-CoA dehydrogenase (VLCAD) and long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD) deficiencies.
DESIGN: Eleven subjects completed two 45-minute, moderate intensity, treadmill exercise studies in a randomized crossover design. An isocaloric oral dose of CHO or MCT-oil was administered prior to exercise; hemodynamic and metabolic indices were assessed during exertion.
RESULTS: When exercise was pretreated with MCT, respiratory exchange ratio (RER), steady state heart rate and generation of glycolytic intermediates significantly decreased while circulating ketone bodies significantly increased.
CONCLUSIONS: MCT supplementation prior to exercise increases the oxidation of medium chain fats, decreases the oxidation of glucose and acutely lowers cardiac workload during exercise for the same amount of work performed when compared with CHO pre-supplementation. We propose that MCT may expand the usable energy supply, particularly in the form of ketone bodies, and improve the oxidative capacity of the heart in this population.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030098      PMCID: PMC3253922          DOI: 10.1016/j.ymgme.2011.09.030

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  19 in total

1.  Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.

Authors:  C Dionisi Vici; A B Burlina; E Bertini; C Bachmann; M R Mazziotta; F Zacchello; G Sabetta; D E Hale
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

2.  Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease.

Authors:  J D Shoemaker; W H Elliott
Journal:  J Chromatogr       Date:  1991-01-02

3.  Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues.

Authors:  D H Williamson; M W Bates; M A Page; H A Krebs
Journal:  Biochem J       Date:  1971-01       Impact factor: 3.857

4.  Effect of ketones on metabolism of FFA by dog myocardium and skeletal muscle in vivo.

Authors:  J R Little; M Goto; J J Spitzer
Journal:  Am J Physiol       Date:  1970-11

5.  Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.

Authors:  D Bonnet; D Martin; E Villain; P Jouvet; D Rabier; M Brivet; J M Saudubray
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

6.  Sensitivity of glucose uptake and lipolysis of white adipocytes of the rat to insulin and effects of some metabolites.

Authors:  A Green; E A Newsholme
Journal:  Biochem J       Date:  1979-05-15       Impact factor: 3.857

7.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients.

Authors:  Margarethe E J den Boer; Ronald J A Wanders; Andrew A M Morris; Lodewijk IJlst; Hugo S A Heymans; Frits A Wijburg
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

8.  Competition between fatty acids and carbohydrate or ketone bodies as metabolic fuels for the isolated perfused heart.

Authors:  R G Forsey; K Reid; J T Brosnan
Journal:  Can J Physiol Pharmacol       Date:  1987-03       Impact factor: 2.273

9.  Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography.

Authors:  J L Vanoverschelde; W Wijns; J Kolanowski; A Bol; P M Decoster; C Michel; M Cogneau; G R Heyndrickx; B Essamri; J A Melin
Journal:  Am J Physiol       Date:  1993-03

10.  Acylcarnitine analysis by tandem mass spectrometry.

Authors:  Emily H Smith; Dietrich Matern
Journal:  Curr Protoc Hum Genet       Date:  2010-01
View more
  20 in total

1.  Successful weight loss in two adult patients diagnosed with late-onset long-chain Fatty Acid oxidation defect.

Authors:  H Zweers; C Timmer; E Rasmussen; M den Heijer; H de Valk
Journal:  JIMD Rep       Date:  2012-03-10

Review 2.  The Genetic Challenges and Opportunities in Advanced Heart Failure.

Authors:  Fady Hannah-Shmouni; Sara B Seidelmann; Sandra Sirrs; Arya Mani; Daniel Jacoby
Journal:  Can J Cardiol       Date:  2015-08-21       Impact factor: 5.223

3.  Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart.

Authors:  R Costa; A Morrison; J Wang; C Manithody; J Li; A R Rezaie
Journal:  J Thromb Haemost       Date:  2012-09       Impact factor: 5.824

4.  Higher dietary protein intake preserves lean body mass, lowers liver lipid deposition, and maintains metabolic control in participants with long-chain fatty acid oxidation disorders.

Authors:  Melanie B Gillingham; Gabriela Elizondo; Annie Behrend; Dietrich Matern; Dale A Schoeller; Cary O Harding; Jonathan Q Purnell
Journal:  J Inherit Metab Dis       Date:  2019-07-24       Impact factor: 4.982

5.  Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.

Authors:  Melanie B Gillingham; Stephen B Heitner; Julie Martin; Sarah Rose; Amy Goldstein; Areeg Hassan El-Gharbawy; Stephanie Deward; Michael R Lasarev; Jim Pollaro; James P DeLany; Luke J Burchill; Bret Goodpaster; James Shoemaker; Dietrich Matern; Cary O Harding; Jerry Vockley
Journal:  J Inherit Metab Dis       Date:  2017-09-04       Impact factor: 4.982

Review 6.  Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.

Authors:  Sara Tucci
Journal:  J Inherit Metab Dis       Date:  2017-02-28       Impact factor: 4.982

7.  Sports in LCHAD Deficiency: Maximal Incremental and Endurance Exercise Tests in a 13-Year-Old Patient with Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency (LCHADD) and Heptanoate Treatment.

Authors:  D Karall; G Mair; U Albrecht; K Niedermayr; T Karall; W Schobersberger; S Scholl-Bürgi
Journal:  JIMD Rep       Date:  2014-07-06

8.  Reactivation of fatty acid oxidation by medium chain fatty acid prevents myocyte hypertrophy in H9c2 cell line.

Authors:  Saifudeen Ismael; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2020-09-30       Impact factor: 3.396

9.  Management of an LCHADD Patient During Pregnancy and High Intensity Exercise.

Authors:  D C D van Eerd; I A Brussé; V F R Adriaens; R T Mankowski; S F E Praet; M Michels; M Langeveld
Journal:  JIMD Rep       Date:  2016-06-23

10.  Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.

Authors:  Eric S Goetzman
Journal:  Curr Genet Med Rep       Date:  2017-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.